Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance

Ethnicity and Disease

Volumn 12, Issue 4, 2002, Pages

  Amoah, Albert G B ^a   Schuster, Dara P ^b   Gaillard, Trudy ^b   Osei, Kwame ^b  

^a UNIVERSITY OF GHANA   (Ghana)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY DISTRIBUTION; BODY FAT; BODY MASS; CARDIOVASCULAR RISK; CELL FUNCTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GHANA; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET CELL; POPULATION RESEARCH; RISK FACTOR; SCREENING TEST;

ADULT; AGED; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; GHANA; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MIDDLE AGED; RANDOM ALLOCATION; REGRESSION ANALYSIS; RISK FACTORS;

EID: 0036763610     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. King H, Rewer M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care. 1993;16:157-177.
2. King H, Aubert R, Herman WH. Global burden of diabetes. Prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414-1433.
3. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74. Diabetes. 1987;36:523-524.
4. Sidibe el-H. Diabetes mellitus in Sub-Saharan Africa. 1998;8:342-346.
5. McLarty DG, Pollitt C, Swai AB. Diabetes in Africa. Diabetes Med. 1990;7:670-684.
6. Erasmus RT, Blanco E, Okesina AB, Marsha T, Gqweta Z, Mesa JA. Prevalence of diabetes mellitus and impaired glucose tolerance in factory workers from Tyrabskei, South Africa. S Afr Med J. 2001;91:157-160.
7. Owusu SK. Diabetes in Ghana. Ghana Med J. 1976;6:111-117.
8. Swai AB, Lutale J, McLarty DG. Diabetes in tropical Africa: a prospective study, 1981-1987. I. Characterization of newly presenting patients in Dar es Saleem, Tanzania, 1981-1987. BMJ. 1990;300:1103-1106.
9. Kalk WJ, Joannou J, Ntsepo S, Mohamed P, Becker PJ. Ethnic differences in the clinical and laboratory associations with retinopathy in adult onset diabetes: studies in patients of African, European, and Indians origin. J Intern Med. 1997;241:31-37.
10. Mbanya JC, Ngogang J, Salah JN, Minkoulou E, Balkau B. Prevalence of NIDDM and impaired glucose tolerance in a rural and an urban population in Cameroon. Diabetologia. 1997;40:824-829.
11. Charlton KE, Levitt NS, Lombard CJ. The prevalence of diabetes mellitus and associated risk factors in elderly colored South Africans. S Afr Med J. 1997;87:364-367.
12. Rotimi CN, Cooper RS, Okosun IS, et al. Prevalence of diabetes and impaired glucose tolerance in Nigerians, Jamaicans, and US Blacks. Ethn Dis. 1999;7:190-200.
13. Mbanya JC, Pani LN, Mbanya DN, Sobngwi E, Ngogang J. Reduced insulin secretion of offspring of African type 2 diabetic parents. Diabetes Care. 2000;23:1761-1765.
14. Chale SS, Swai AB, Mujinja PG, McLarty DG. Must diabetes be fatal in Africa? Study of cost of treatment. BMJ. 1992;304:1215-1218.
15. Levitt NS, Bradshaw D, Zwarenstein MF, Bawa AA, Maphumoto S. Audit of public sector primary diabetes care in Cape Town, South Africa. High prevalence of complications, uncontrolled hyperglycemia, and hypertension. Diabetes Med. 1997;14:1073-1077.
16. Levetan BN, Levitt NS, Bonnici F. Hyperglycemic emergencies are common problem. S Afr Med J 1997;87:368-370.
17. Alberti KGMM. Insulin dependent diabetes: a lethal disease in the developing world. BMJ. 1999;309:754-755.
18. Joffe B, Zimmer P. The thrifty genotype in type 2 diabetes: an unfinished symphony moving to its finale. Endocrine. 1998;9:139-141.
19. DeFronzo RA, Ferrannini E, Simonson DC. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism. 1989;38:387-395.
20. Reaven GM, Hollenbeck CB, Chen Y-D. Relationship between glucose tolerance, insulin secretion, and insulin action of non-obese individuals with varying degrees of glucose tolerance. Diabetologia. 1989;32:52-55.
21. Weyer C, Tataranni PA, Bogardus C, Pratley RE. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care. 2000;24:89-94.
22. Lewitt NSM, Steyn K, Lambert EV, et al. Modifiable risk factors for type 2 diabetes mellitus in the peri-urban community in South Africa. Diabetes Med. 1999;16:946-950.
23. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
24. Seidell JC. Obesity, insulin resistance, and diabetes - a worldwide epidemic. Br J Nutr. 2000;83:S5-S8.
25. Ferrannini E, Haffner SM, Mitchell BD, et al. Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 1991;34:416-422.
26. DeFronzo RA, Ferrannini E. Insulin resistance: a multi-faceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-194.
27. Osei K, Schuster DP. Metabolic characteristics of African descendants: a comparative study of African Americans and Ghanaian immigrants using minimal model analysis. Diabetologia. 1995;38:1103-1109.
28. Amoah ABG, Owusu SK, Ayittey OM, Schuster DP, Osei K. Minimal model analyses of beta cell secretion, insulin sensitivity, and glucose effectiveness in glucose tolerant, first degree relatives of Ghanaian patients with type 2 diabetes and healthy control subjects. Ethn Dis. 2001;11:201-210.
29. Levitt NS, Unwin N, Brashaw D, et al. Application of the new ADA criteria for the diagnosis of diabetes in Sub-Saharan Africa. American Diabetes Association. Diabetic Med. 2000;17:381-385.
30. Mathews DR, Hosker JP, Rudenski AS, Taylor BA, Treacher DF, Turner RC. Homeostasis model assessment insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
31. DeFronzo RA, Tobin JD, Andres R. The glucose clamp technique: a method for the quantification of beta cell sensitivity to glucose and of tissue sensitivity to insulin. Am J Physiol, 1979;237:E214-E223.
32. Bergman RN, Phillips LS, Cobelli C. Physiological evaluation of factor controlling glucose tolerance in man. J Clin Invest. 1981;68:1456-1467.
33. Osei K, Schuster DP. Decreased insulin-mediated but not non-insulin dependent glucose disposal in glucose intolerance and type 2 diabetes in African (Ghanaian) immigrants. Am J Med Sci. 1996;311:113-121.
34. Motala M, Omar MAK. Evidence for impaired pancreatic beta cell function in southern African Indians with impaired glucose tolerance. Diabetic Med. 1994;11:437-444.
35. Joffe BI, Panz VR, Ing JR, Rall FJ, Sftel HC. Pathogenesis of non-insulin dependent diabetes mellitus in the Black population of southern Africa. Lancet. 1992;340:460-462.
36. Osei K, Gaillard T, Schuster DP. Pathogenetic mechanism of impaired glucose tolerance and type 2 diabetes in African Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness. Diabetes Care. 1997;20:396-404, 444.
37. Ezenwaka CE, Akanji AO, Osei K, et al. Glucose and serum insulin responses to intravenous glucose challenge in relatives of Nigerian patients with non-insulin dependent diabetes mellitus. Diabetes Res Clin Pract. 1993;20:175-181.
38. Osei K, Schuster DP. Ethnic differences in secretion, sensitivity, and hepatic extraction of insulin in Black and White Americans. Diabetic Med. 1994;11:755-762.
39. Cruickshank JK, Cooper J, Burnett M, MacDuff J, Drubra U. Ethnic differences in fasting plasma c-peptide and insulin in relation to glucose tolerance and blood pressure. Lancet. 1991;11:338-342.
40. Fontbonne A, Papoz L, Eschwege E, Roger M, Saint-Paul M, Simon D. Features of insulin resistance syndrome in men from French Caribbean Islands. The Telecom Study. Diabetes. 1992;41:1385-1389.
41. Martin BC, Warram JH, Krowleski AS, Bergman RW, Soeldner JS, Kahn CR. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a follow-up study. Lancet. 1992;340(1):925-929.
42. Osei K, Schuster DP, Owusu SK, Amoah AGB. Race and ethnicity determine serum insulin and c-peptide concentrations and hepatic insulin extraction and insulin clearance: comparative studies of three populations of West African Ancestry and White Americans. Metabolism. 1997;46:53-58.
43. Osei K, Gaillard T, Schuster DP. Cardiovascular risk factors in African Americans with varying degrees of glucose intolerance. Diabetes Care. 1999;22:1588-1590.
44. Cowie CC, Howard BV, Harris MI. Serum lipoproteins in African Americans and Whites with non-insulin dependent diabetes in the US population. Circulation. 1991;91:1185-1191.
45. Metcalf PA, Sharrett AR, Folsom AR, et al. African-American-White differences in lipids, lipoproteins, and apolipoprotein, by educational attainment, among middle-aged adults: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 1998;148:750-760.
46. Osei K. Metabolic consequences of the West African Diaspora: lessons from the thrifty gene. J Lab Clin Med. 1999;133:98-111.
47. Young CA, Kumar S, Young MJ, Boulton AJ. Excess maternal history of diabetes in Caucasian and African-origin non-insulin dependent diabetic patients suggests maternal factors in disease transmission. Diabetes Res Clin Pract. 1995;28:47-49.
48. Crowther NJ, Cameron N, Trusler J, Gray IP. Association between poor glucose tolerance and rapid postnatal weight gain in seven-year-old children. Diabetologia. 1997;41:1163-1167.